Pharma outsourcing: people on the move

By Phil Taylor

- Last updated on GMT

Related tags: Vice president, Senior vice president, Pharmacology presents its periodic round-up of executive appointments in the contract services sector.

PDI ​has appointed Nancy Lurker​ as CEO and a member of the company's board of directors. Previously Lurker was senior vice president and chief marketing officer for Novartis Pharmaceuticals Corp.

INC Research​ has appointed Dr. Renee Simar​ as its principle paediatric strategist. In this role, Simar will be leading the INC Research pediatric team in developing programme strategy and considerations for clinical trials in neonates, children and adolescents.

Sancilio & Company​ has named Dr. Rizwan Kazmi​ to the post of senior director of pharmaceutical R&D.

Bernard Mulder​ has joined high-throughput R&D specialist Avantium Technologies​ as global vice president, business development pharma. He will be charged with developing the firm’s pharmaceutical service business.

Rich Fante​ has been named president of AstraZeneca​ 's US business. Fante takes over from Tony Zook​, whose role was expanded after recently being named president of MedImmune, AstraZeneca’s wholly-owned biologics business.

etrials Worldwide​ has named Denis Connaghan​ as its new president and CEO, replacing Chuck Piccirillo who has served as interim president and CEO since July 10. Piccirillo has returned to his former role as etrials’ vice president of technology.

Halloran Consulting Group​, which provides clinical development services for emerging and established life sciences companies, has named Laura Araujo​ as senior director of quality management and Tina Forrister​ as senior associate for training and development.

Specialty contract research organisation Clinilabs​ has appointed Dr. Howard Greenberg​ as the new senior medical director of its Clinical Pharmacology unit.

John Tomera​ has joined WorldCare Clinical​, a specialist in imaging for clinical trials in the pharmaceutical, biotechnology, and medical device industries, as director of regulatory affairs and associate medical director.

Dr. Conrad Heilman​ will be appointed president and CEO of Tunnell Consulting​, effective July 2009. Heilman will serve immediately as chief operating officer and retain that post until he assumes the other roles. He succeeds Dr. Joseph Tempio.

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Related suppliers

Follow us


View more